Log In
Print
BCIQ
Print
Print this Print this
 

sNN0029

  Manage Alerts
Collapse Summary General Information
Company Newron Pharmaceuticals S.p.A.
DescriptionVascular endothelial growth factor (VEGF) protein
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase I/II
IndicationAmyotrophic lateral sclerosis (ALS)
Partner

Roche
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today